Apellis Pharmaceuticals | 4:持股变动声明-高管 Sullivan Timothy Eugene
04/19 19:30 (美东)
Apellis Pharmaceuticals | 4:持股变动声明-董事 Dunlop A. Sinclair
04/15 16:15 (美东)
Apellis Pharmaceuticals | 4:持股变动声明-高管 Deschatelets Pascal
04/09 16:30 (美东)
Apellis Pharmaceuticals | 4:持股变动声明-高管 Sullivan Timothy Eugene
04/02 16:14 (美东)
Apellis Pharmaceuticals | 4:持股变动声明-董事 Dunlop A. Sinclair
03/20 17:23 (美东)
Apellis Pharmaceuticals | 4:持股变动声明-高管 DeLong Mark Jeffrey
03/19 16:09 (美东)
Apellis Pharmaceuticals | 4:持股变动声明-高管 Chopas James George
03/18 16:21 (美东)
Apellis Pharmaceuticals | 4:持股变动声明-高管 Nicholson Nur
03/14 16:25 (美东)
Apellis Pharmaceuticals | 4:持股变动声明-高管 Deschatelets Pascal
03/11 16:16 (美东)
Apellis Pharmaceuticals | 4:持股变动声明-高管 Watson David O.
03/08 07:50 (美东)
Apellis Pharmaceuticals | 4:持股变动声明-高管 Francois Cedric
03/05 16:13 (美东)
Apellis Pharmaceuticals | 4:持股变动声明-高管 Sullivan Timothy Eugene
03/05 16:13 (美东)
Apellis Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-EcoR1 Capital, LLC(9.4%),Oleg Nodelman(9.4%)等
02/14 17:23 (美东)
Apellis Pharmaceuticals | SC 13G:超过5%持股股东披露文件-T. Rowe Price Investment Management, Inc.(5.3%)
02/14 14:31 (美东)
Apellis Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Avoro Capital Advisors LLC(9.9%),Behzad Aghazadeh(9.9%)
02/14 09:27 (美东)
Apellis Pharmaceuticals | 4:持股变动声明-高管 Townsend Adam J.
02/13 18:06 (美东)
Apellis Pharmaceuticals | 4:持股变动声明-高管 Watson David O.
02/13 17:47 (美东)
Apellis Pharmaceuticals | 4:持股变动声明-高管 Sullivan Timothy Eugene
02/13 17:11 (美东)
Apellis Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(8.06%)
02/13 17:01 (美东)
Apellis Pharmaceuticals | 4:持股变动声明-高管 Francois Cedric
02/13 16:53 (美东)
暂无数据
暂无数据